HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Volume-reserving Surgery after Photodynamic Therapy for Biliary Papillomatosis: A Case Report.

Abstract
Biliary papillomatosis is rare, and its pathogenic mechanisms are not yet clear. Because of its high risk for malignancy transformation, surgical resection is regarded as a standard treatment. Photodynamic therapy (PDT) has been used by the intravenous administration of hematoporphyrin derivative followed by laser exposure. A photochemical process causes disturbance of the microvascular structure and degradation of membrane. Cholangitis is a major complication after PDT. A healthy 56-year-old man was diagnosed with biliary papillomatosis involving the common hepatic duct, both proximal intrahepatic bile ducts (IHD), and the right posterior IHD. After biliary decompression by endoscopic nasobiliary drainage, PDT was performed to avoid extensive liver resection and recurrence using endoscopic retrograde cholangiographic guidance. After portal vein embolization, the patient underwent extended right hemihepatectomy. Following administration of chemoradiation therapy with tegafur-uracil and 45 Gy due to local recurrence at postoperative 13 months, there was no local recurrence or distant metastases. This is the first case report on PDT for biliary papillomatosis in Korea. Preoperative PDT is beneficial for reducing the lesion in diffuse or multifocal biliary papillomatosis and may lead to curative and volume reserving surgery. Thus, PDT could improve the quality of life and prolong life expectation for biliary papillomatosis patients.
AuthorsChin Ock Cheong, Jin Hong Lim, Joon Seung Park, Seung Woo Park, Hyun Ki Kim, Kyung Sik Kim
JournalThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (Korean J Gastroenterol) Vol. 66 Issue 1 Pg. 55-8 (Jul 2015) ISSN: 2233-6869 [Electronic] Korea (South)
PMID26194131 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Tegafur
  • Uracil
Topics
  • Antineoplastic Agents (therapeutic use)
  • Bile Duct Neoplasms (diagnosis, drug therapy, surgery)
  • Bile Ducts, Intrahepatic (pathology)
  • Embolization, Therapeutic
  • Gamma Rays
  • Hepatectomy
  • Hepatic Duct, Common (pathology)
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Papilloma (diagnosis, drug therapy, surgery)
  • Photochemotherapy
  • Tegafur (therapeutic use)
  • Uracil (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: